These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25510039)

  • 1. [Induced abortion--clinical problems, regulatory gaps, chaos. How much longer?].
    Andreeva A; Marinov B; Tzankova M
    Akush Ginekol (Sofiia); 2014; 53 Suppl 1():29-32. PubMed ID: 25510039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of gestational age on the outcome of second-trimester termination of pregnancies for foetal abnormalities.
    Lo TK; Lau WL; Lai FK; Lam H; Tse HY; Leung WC; Chin RK
    Prenat Diagn; 2008 Jun; 28(6):508-11. PubMed ID: 18509869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The termination of pregnancy in the second trimester with rivanol].
    Vlasova D; Tsankova M
    Akush Ginekol (Sofiia); 1996; 35(1-2):16-7. PubMed ID: 8967530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective second-trimester termination of the anomalous fetus in twin pregnancies.
    Chitkara U; Berkowitz RL; Wilkins IA; Lynch L; Mehalek KE; Alvarez M
    Obstet Gynecol; 1989 May; 73(5 Pt 1):690-4. PubMed ID: 2649817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second trimester abortion for fetal abnormality.
    Lyus R; Robson S; Parsons J; Fisher J; Cameron M
    BMJ; 2013 Jul; 347():f4165. PubMed ID: 23823994
    [No Abstract]   [Full Text] [Related]  

  • 6. Abortion barriers and perceptions of gestational age among women seeking abortion care in the latter half of the second trimester.
    Janiak E; Kawachi I; Goldberg A; Gottlieb B
    Contraception; 2014 Apr; 89(4):322-7. PubMed ID: 24332434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socio-demographic factors and indications in second trimester voluntary abortion.
    Carriero C; Ceci OR; Melilli GA; Fanelli M; Nappi L; Di Gesù G; Ferreri R
    Panminerva Med; 2000 Mar; 42(1):33-7. PubMed ID: 11019602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilation and evacuation for second-trimester genetic pregnancy termination.
    Shulman LP; Ling FW; Meyers CM; Shanklin DR; Simpson JL; Elias S
    Obstet Gynecol; 1990 Jun; 75(6):1037-40. PubMed ID: 2342729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.
    Vitner D; Deutsch M; Paz Y; Khatib N; Baltiter T; Rosenberg S; Lowenstein L
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):140-3. PubMed ID: 21507550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inside look at partial birth abortion.
    Lowe LR
    Thurgood Marshall Law Rev; 1998-1999; 24():327-57. PubMed ID: 16180289
    [No Abstract]   [Full Text] [Related]  

  • 11. Second-trimester pregnancy termination: comparison of three different methods.
    Makhlouf AM; Al-Hussaini TK; Habib DM; Makarem MH
    J Obstet Gynaecol; 2003 Jul; 23(4):407-11. PubMed ID: 12881083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prenatal diagnosis of non-viable fetuses caused by developmental disorders--an indication for abortion for fetal reasons?].
    Wisser J; Knitza R; Schmid-Tannwald I; Strowitzki T; Nerlich A; Hepp H
    Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):8-14. PubMed ID: 3552856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of women who undergo second-trimester abortion in the setting of a fetal anomaly.
    Kerns JL; Swanson M; Pena S; Wu D; Shaffer BL; Tran SH; Steinauer JE
    Contraception; 2012 Jan; 85(1):63-8. PubMed ID: 22067803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for routine sonography prior to late abortion.
    Chervenak FA; Dorfman SF; Bowers C; Berkowitz RL; Holder AR; Ehrenkranz RA; Furlong R; Hobbins JC
    N Y State J Med; 1985 Jan; 85(1):4-5. PubMed ID: 3883251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
    Stoutjesdijk JA; Alsma J; Wildschut HI
    Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1293-6. PubMed ID: 15279214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
    Hagar DL; Valley MT; Rayburn WF; Carey JC
    J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When does a fetus become a child in need of an advocate? Focusing on fetal pain.
    McDonald TB
    Child Leg Rights J; 1997; 17(2):12-9. PubMed ID: 12159907
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
    De Heus R; Graziosi GC; Christiaens GC; Bruinse HW; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):16-21. PubMed ID: 15294361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of the severe fetalanomalies terminated in general obstetrics department for 4,5 years period].
    Tsankova M; Marinov B
    Akush Ginekol (Sofiia); 2011; 50(4):22-9. PubMed ID: 22479893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.